Therapeutic effects were sustained off treatment, with persistent reduction in HbA1c and improvement in beta-cell function 3 months after last dose, suggesting disease-modifying potential of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio PHOENIX — An SGLT2 inhibitor recently ...

An international meta-analysis including nearly 18,000 patients from five clinical trials was coordinated by the CNIC in collaboration with institutions in four other countries ...

REDWOOD CITY, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced the presentation of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A single 14-day course of the monoclonal antibody ...

A major analysis led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in collaboration with international ...